# A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose Administration

> **NCT05995366** · PHASE1 · COMPLETED · sponsor: **AbbVie** · enrollment: 7 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** ABBV-903

## Key facts

- **NCT ID:** NCT05995366
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-18
- **Primary completion:** 2023-10-13
- **Final completion:** 2023-10-13
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05995366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05995366, "A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose Administration". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT05995366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*